In spite of the above mentioned positive effects, in our experimental model, the bradykinin B1 receptor antagonist treatment had only marginal, non-significant effect on hypertension-induced vascular wall thickening in great vessels characterized by IMT. Here, BDKRB1 is linked to hypertensive disorder.